13. Le Moal M. and Simon H. (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol.
Rev. 71, 155–234.
14. Maes M., Maes L. and Suy E. (1990) Symptom profiles of biological markers in depression: a multivariate study.
Psychoneuroendocrinology 15, 29–37.
15. Nelson J., Bowers M. and Sweeney D. (1979) Exacerbation of psychosis by tricyclic antidepressants in delusional
depression. Am. J. Psychiat. 136, 574–576.
16. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, San Diego.
17. Porsolt R. D., Le Pichon M. and Jalfre M. (1977) Depression: a new animal model sensitive to antidepressant
treatments. Nature 266, 730–732.
18. Shatzberg A. F., Rothschild A. J., Langlais P. J., Bird E. D. and Cole J. O. (1985) A corticosteroid/dopamine
hypothesis for psychotic depression and related states. J. Psychiat. 19, 57–64.
19. Slater P. J. B. (1978) Data collection. In Quantitative Ethology (ed. Colgan P. W.), pp. 7–24. Wiley, New York.
20. Tanda G., Carboni E., Frau R. and Di Chiara G. (1994) Increase of extracellular dopamine in the prefrontal cortex:
a trait of drugs with antidepressant potential? Psychopharmacology 115, 285–288.
21. Thiebot M. H. and Martin P. (1991) EVects of benzodiazepines, 5-HT1A agonists and 5-HT3 antagonists in animal
models sensitive to antidepressant drugs. In 5-HT1A Agonists, 5-HT3 Antagonists and Benzodiazepines. Their
Comparative Pharmacology (eds Rodgers R. J. and Cooper S. J.), pp. 159–195. Wiley, New York.
